Chris Morrison
Impact in
- Rehabilitation top 10%
- Wound Healing and Treatments
-
- Chemical Synthesis and Analysis
- RNA Interference and Gene Delivery
- TGF-β signaling in diseases
Papers in
-
- Pharmaceutical Economics and Policy 16
-
- Private Equity and Venture Capital 3
- Financial Analysis and Corporate Governance 2
- Co-authors
- David Cox (1 shared paper)N J Lüscher (1 shared paper)Gary McMaster (1 shared paper)Walter O. Seiler (1 shared paper)Peter Schmid (1 shared paper)Graeme Bilbe (1 shared paper)H.B. Stähelin (1 shared paper)
- Journals
- Nature Biotechnology (19 papers)Nature Reviews Drug Discovery (8 papers)The Journal of Pathology (1 paper)Vaccine (1 paper)Immunology Today (1 paper)
- Partner nations
- SwitzerlandUnited Kingdom
In The Last Decade
Chris Morrison
29 papers receiving 726 citations
Peers
Comparison fields: 5 of 82
- Rehabilitation 57
- Molecular Biology 317
- Radiology, Nuclear Medicine and Imaging 95
- Immunology 62
- Applied Microbiology and Biotechnology 7
Countries citing papers authored by Chris Morrison
This map shows the geographic impact of Chris Morrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Morrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Morrison more than expected).
Fields of papers citing papers by Chris Morrison
This network shows the impact of papers produced by Chris Morrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Morrison. The network helps show where Chris Morrison may publish in the future.
Co-authors
The 7 scholars most cited alongside Chris Morrison, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 170 | |
| 2 | 2019 | 113 | |
| 3 | 1993 | 112 | |
| 4 | 2015 | 86 | |
| 5 | 2016 | 65 | |
| 6 | 2015 | 33 | |
| 7 | 2016 | 32 | |
| 8 | 2020 | 18 | |
| 9 | 2017 | 16 | |
| 10 | 2019 | 15 | |
| 11 | 2017 | 13 | |
| 12 | 2016 | 12 | |
| 13 | 2017 | 11 | |
| 14 | 2016 | 10 | |
| 15 | 2015 | 9 | |
| 16 | 2015 | 8 | |
| 17 | 2015 | 7 | |
| 18 | 2015 | 6 | |
| 19 | 2015 | 6 | |
| 20 | 2014 | 4 |
About Chris Morrison
Chris Morrison is a scholar working on Economics and Econometrics, Accounting, Public Health, Environmental and Occupational Health, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 30 papers that have together received 769 indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (16 papers), Biotechnology and Related Fields (7 papers), Private Equity and Venture Capital (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), T-cell and B-cell Immunology (2 papers), Virus-based gene therapy research (2 papers), Financial Analysis and Corporate Governance (2 papers) and RNA Interference and Gene Delivery (1 paper). The work is most often cited by research in Rehabilitation (57 citations), Molecular Biology (317 citations), Radiology, Nuclear Medicine and Imaging (95 citations), Immunology (62 citations) and Applied Microbiology and Biotechnology (7 citations). Chris Morrison has collaborated with scholars based in Switzerland and United Kingdom. Frequent co-authors include David Cox, N J Lüscher, Gary McMaster, Walter O. Seiler, Peter Schmid, Graeme Bilbe and H.B. Stähelin. Their work appears in journals such as Nature Biotechnology, Nature Reviews Drug Discovery, The Journal of Pathology, Vaccine and Immunology Today.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.